( NASDAQ-NMS:ELOS )

News from Syneron Medical Ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 15, 2017, 07:00 ET Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million

Total Revenue Grows 5.1% in 4Q16 and 7.3% for Full Year Emerging Products¹ Revenue Grows 25.0% in 4Q16 and 42.1% for Full Year, Reaching...


Feb 13, 2017, 09:00 ET Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare Conference

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, and...


Jan 31, 2017, 16:05 ET Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today the strengthening of its executive management team...


Jan 30, 2017, 09:00 ET Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017

Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter and full year...


Nov 11, 2016, 16:00 ET Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is...


Nov 09, 2016, 07:00 ET Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million

Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended...


Nov 08, 2016, 09:00 ET Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The Appearance Of Cellulite, As Supported By Long Term Data

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it has achieved two major milestones to...


Oct 17, 2016, 07:00 ET Syneron Medical Strengthens Senior Management and Announces Preliminary Third Quarter 2016 Revenue

Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced that it is strengthening its management team with...


Aug 04, 2016, 07:00 ET Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended...


Jul 25, 2016, 09:00 ET Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength

 Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that the PicoWay® picosecond laser...


Jul 18, 2016, 09:00 ET Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announces the U.S. Food and Drug Administration (FDA) clearance of...


Jul 18, 2016, 08:30 ET Syneron Medical to Report Second Quarter 2016 Financial Results on August 4, 2016

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release second quarter 2016 financial...


May 19, 2016, 07:00 ET Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended...


Apr 27, 2016, 09:00 ET Syneron Medical to Report First Quarter 2016 Financial Results on May 19, 2016

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release first quarter 2016...


Mar 21, 2016, 16:05 ET Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that its Annual Report on Form 20-F,...


Mar 05, 2016, 14:13 ET Syneron Medical and Allergan Announce U.S. Aesthetics Collaboration

Syneron Medical Ltd. (NASDAQ: ELOS) a leading global aesthetic device company, and Allergan plc, (NYSE: AGN) a leading global pharmaceutical...


Mar 03, 2016, 09:00 ET Syneron Candela to Introduce New Technologies at the 2016 American Academy of Dermatology (AAD) Annual Meeting

Syneron Medical Ltd. (NASDAQ: ELOS) a global market leader in the aesthetic medical device marketplace, this week will announce three new product...


Feb 22, 2016, 07:00 ET Syneron Medical Reports Record Fourth Quarter 2015 Revenue of $78.9 Million

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three and twelve month...


Feb 05, 2016, 16:09 ET Syneron Medical to Participate in Leerink Partners 5th Annual Global Healthcare Conference

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that William Griffing, Chief Executive Officer...


Feb 03, 2016, 16:01 ET Syneron Medical to Report Fourth Quarter 2015 and Full Year 2015 Financial Results on February 22, 2016

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter 2015 and...


Jan 11, 2016, 16:05 ET Syneron Medical Provides Preliminary Fourth Quarter 2015 Revenue

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today provided preliminary unaudited fourth quarter 2015...


Dec 01, 2015, 09:00 ET Syneron to Host 2015 Analyst Day on December 3, 2015

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it will host an Analyst Day meeting on...


Nov 13, 2015, 10:10 ET Syneron Medical to Participate in Three Investor Conferences in November

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that management is scheduled to participate in...


Nov 11, 2015, 07:00 ET Syneron Medical Reports Third Quarter 2015 Revenue of $62.1 Million

 Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period...


Nov 11, 2015, 06:59 ET Syneron Medical Appoints Jeff Nardoci as President of North America Body Shaping Group

Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that it has enhanced its North American leadership...